CING

Conviction 12HealthcareScan · Thu, Jun 25, 2026

Bearish engulfing

CING$4.77-0.83%

ResistanceSupportVol 14Insider buy

Vol MA14 347.01K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Cingulate Inc.PHARMACEUTICAL PREPARATIONSwww.cingulate.com ↗

Price4.77

Change-0.83%

Gap+1.25%

Rel volume0.33×

Avg volume755.59K

Avg $ vol3.29M

SMA 204.67

SMA 504.89

SMA 2004.97

Price vs 50-2.37%

Price vs 200-4.07%

MA stackbearish

50/200 crossdeath · 4d

Supertrenddown · 5.18

RSI (14)49

MACD hist0.03

MACD cross—

Stoch %K / %D46 / 53

ADX (14)10

+DI / −DI19 / 18

RSI divergence—

MACD divergence—

ATR %+9.23%

ADR %10.45%

52w high11.66

52w low3.33

From 52w high-59.09%

Above 52w low+43.24%

New 52w highNo

SqueezeOff

Bollinger width32.08%

%B0.56

Donchian pos75.23%

Donchian high5.30

Donchian low3.16

AVWAP (52w high)5.47

vs AVWAP high-12.81%

AVWAP (52w low)4.39

vs AVWAP low+8.71%

OBV trendFlat

Chaikin MF (20)0.00

Today vs 20d0.33×

Avg vol (14d)347.01K

Avg vol (20d)755.59K

Avg $ vol (20d)3.29M

Market cap63.33M

RS 3m (vs SPY)-40.57%

RS 6m (vs SPY)+13.42%

RS line new highNo

Trend template3/8

Technical rank54.4

1 week-6.84%

1 month-0.21%

3 months-25.00%

6 months+14.11%

1 year+16.91%

YTD+8.90%

P/E-2.82

P/B3.36

P/S—

P/FCF-3.64

EPS-4.44

Div yield—

ROE-119.00%

ROA-72.74%

Debt/Eq—

Current2.55

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-35.57%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value37.43M

Revenue—

Net income-9.31M

Gross profit—

Free cash flow-17.41M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out13.47M

Employees14

ListedWed, Dec 8, 2021

Free float10.47M

Float %95.7%

Short interest1.96M

Days to cover3.1d

Short volume64.0%

Squeeze score69 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.95 vs −$0.53

Last surprise-79.3% miss

Setup gradeD

Conviction12 / 100

Pattern quality—

Tech rank54.4 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish engulfing

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CING

All disclosures →

No recent disclosed trades by Congress in CING. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CING · 4 buys

Insider	Side	Shares	Value	Traded	Filed
Hargroves Thomas Jeffrey Director · Stock Option (right to Buy) · 2026-03-09	Grant	15K	$0	2026-03-09	2026-06-08
Hargroves Thomas Jeffrey Director · Common Stock · 2026-02-13	Buy	97.28K	$490K	2026-02-13	2026-06-08
Hargroves Thomas Jeffrey Director · Warrant to Purchase Common Stock · 2026-02-13	Buy	77.82K	$8K	2026-02-13	2026-06-08
Silva Raul R. EVP and CSO · Stock Option (right to Buy) · 2026-03-31	Grant	3.42K	$0	2026-03-31	2026-05-08

SEC filings

EDGAR filings in CING · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.